The application of selective reaction monitoring confirms dysregulation of glycolysis in a preclinical model of schizophrenia

BACKGROUND: Establishing preclinical models is essential for novel drug discovery in schizophrenia. Most existing models are characterized by abnormalities in behavioral readouts, which are informative, but do not necessarily translate to the symptoms of the human disease. Therefore, there is a nece...

Descripción completa

Detalles Bibliográficos
Autores principales: Martins-de-Souza, Daniel, Alsaif, Murtada, Ernst, Agnes, Harris, Laura W, Aerts, Nancy, Lenaerts, Ilse, Peeters, Pieter J, Amess, Bob, Rahmoune, Hassan, Bahn, Sabine, Guest, Paul C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3359223/
https://www.ncbi.nlm.nih.gov/pubmed/22420779
http://dx.doi.org/10.1186/1756-0500-5-146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3359223/
https://www.ncbi.nlm.nih.gov/pubmed/22420779
http://dx.doi.org/10.1186/1756-0500-5-146

Ejemplares similares